Cardiovascular profile in myotonic dystrophy type 1: Analysis of a case series in a specialized center

被引:12
|
作者
Gomes, Lilian [1 ]
Pereira, Telmo [2 ]
Martins, Luis [1 ]
机构
[1] Hosp Sao Sebastiao, Santa Maria Feira, Portugal
[2] Escola Supert Tecnol Saude Coimbra, Dept Cardiopneumol, Coimbra, Portugal
关键词
Myotonic dystrophy; Cardiomyopathy; Arrhythmia; CARDIAC INVOLVEMENT; REPEAT LENGTH; ELECTROCARDIOGRAM; RECOMMENDATIONS; DISEASE; AGE;
D O I
10.1016/j.repc.2014.06.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Myotonic dystrophy is a multisystem disease associated with cardiac abnormalities that are responsible for high morbidity and mortality. It commonly affects conduction tissue, resulting in changes in heart rate that tend to progress with age. Objective: The aim of the study was to assess overall cardiovascular risk and the risk of arrhythmias in patients with myotonic dystrophy type 1 (DM-1) and to correlate them with genetic study (CTG expansion size). Methods: This retrospective study included 31 DM-1 patients referred to the cardiology department of Centro Hospitalar Entre Douro e Vouga by the neurology department for screening for heart disease. Patients' medical records were consulted for the diagnostic tests performed in the diagnostic cardiology consultation: electrocardiogram (ECG), high-resolution ECG, heart rate variability (HRV), Hotter 24-hour ambulatory ECG and transthoracic echocardiogram (TTE); results of genetic testing were also consulted. Results: Of 31 patients studied, 38% had first-degree atrioventricular block (AVB) and 51% had intraventricular conduction disturbances (62% had late potentials). TTE revealed no structural heart disease. Rare supraventricular and ventricular ectopic beats were the most common arrhythmias on 24-hour Hotter monitoring. The sample showed lower HRV, reflecting vagal dysfunction. Patients with larger CTG expansions had more cardiac abnormalities. Conclusions: Patients with DM-1 had arrhythmic events, with AVB and more significantly intraventricular block, although none had malignant arrhythmias or structural heart disease. No patient died. Patients with larger CTG expansions had greater involvement of cardiac conduction tissue. (C) 2013 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:765 / 772
页数:8
相关论文
共 50 条
  • [31] Risk factors for ischaemic stroke in myotonic dystrophy type 1
    David, Varga
    Brigitta, Perecz
    Andrea, Sipos
    Dalma, Jedlicska
    Endre, Pal
    ORVOSI HETILAP, 2022, 163 (49) : 1962 - 1966
  • [32] Heart Rate Variability in Myotonic Dystrophy Type 1 Patients
    Fregonezi, Guilherme
    Araujo, Thaise
    Dourado Junior, Mario Emilio
    Ferezini, Joceline
    Silva, Ester
    Resqueti, Vanessa
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2012, 98 (04) : 353 - 360
  • [33] Familial left ventricular hypetrabeculation in myotonic dystrophy type 1
    Finsterer, J
    Stöllberger, C
    Kopsa, W
    HERZ, 2003, 28 (05) : 466 - 470
  • [34] Organ Dysfunction and Muscular Disability in Myotonic Dystrophy Type 1
    Kaminsky, Pierre
    Poussel, Mathias
    Pruna, Lelia
    Deibener, Joelle
    Chenuel, Bruno
    Brembilla-Perrot, Beatrice
    MEDICINE, 2011, 90 (04) : 262 - 268
  • [35] Mediastinal and pleural lipomatosis as a manifestation of myotonic dystrophy type 1
    Finsterer, Josef
    Scorza, Fulvio A.
    LUNG INDIA, 2021, 38 (05) : 486 - 488
  • [36] Characteristics of respiratory muscle involvement in myotonic dystrophy type 1
    Henke, Carolin
    Spiesshoefer, Jens
    Kabitz, Hans-Joachim
    Herkenrath, Simon
    Randerath, Winfried
    Brix, Tobias
    Goerlich, Dennis
    Young, Peter
    Boentert, Matthias
    NEUROMUSCULAR DISORDERS, 2020, 30 (01) : 17 - 27
  • [37] Skin features in myotonic dystrophy type 1: An observational study
    Campanati, A.
    Giannoni, M.
    Buratti, L.
    Cagnetti, C.
    Giuliodori, K.
    Ganzetti, G.
    Silvestrini, M.
    Provinciali, L.
    Offidani, A.
    NEUROMUSCULAR DISORDERS, 2015, 25 (05) : 409 - 413
  • [38] Myotonic Dystrophy Type 1 Management and Therapeutics
    Cheryl A. Smith
    Laurie Gutmann
    Current Treatment Options in Neurology, 2016, 18
  • [39] Cardiac manifestations of myotonic dystrophy type 1
    Petri, Helle
    Vissing, John
    Witting, Nanna
    Bundgaard, Henning
    Kober, Lars
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 160 (02) : 82 - 88
  • [40] Cutaneous Neoplasms in Myotonic Dystrophy Type 1
    Marcoval, Joaquim
    Olive, Montserrat
    Bonfill-Orti, Montserrat
    Martinez-Molina, Laura
    Talavera-Belmonte, Ana
    DERMATOLOGY, 2016, 232 (06) : 700 - 703